• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗真菌药物数据库:抗真菌药物耐药性相关基因及突变位点数据库

MycoResistance: a curated resource of drug resistance molecules in Mycobacteria.

机构信息

Department of Microbiology, Harbin Medical University, Xuefu Road, Nangang District, Harbin, China.

Wu Lien-Teh Institute, Harbin Medical University, Xuefu Road, Nangang District, Harbin, China.

出版信息

Database (Oxford). 2019 Jan 1;2019. doi: 10.1093/database/baz074.

DOI:10.1093/database/baz074
PMID:31290951
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6619405/
Abstract

The emergence and spread of drug-resistant Mycobacterium tuberculosis is of global concern. To improve the understanding of drug resistance in Mycobacteria, numerous studies have been performed to discover diagnostic markers and genetic determinants associated with resistance to anti-tuberculosis drug. However, the related information is scattered in a massive body of literature, which is inconvenient for researchers to investigate the molecular mechanism of drug resistance. Therefore, we manually collected 1707 curated associations between 73 compounds and 132 molecules (including coding genes and non-coding RNAs) in 6 mycobacterial species from 465 studies. The experimental details of molecular epidemiology and mechanism exploration research were also summarized and recorded in our work. In addition, multidrug resistance and extensively drug resistance molecules were also extracted to interpret the molecular mechanisms that are responsible for cross resistance among anti-tuberculosis drugs. Finally, we constructed an omnibus repository named MycoResistance, a user friendly interface to conveniently browse, search and download all related entries. We hope that this elaborate database will serve as a beneficial resource for mechanism explanations, precise diagnosis and effective treatment of drug-resistant mycobacterial strains.

摘要

耐药结核分枝杆菌的出现和传播引起了全球关注。为了提高对分枝杆菌耐药性的认识,已经进行了大量研究来发现与抗结核药物耐药性相关的诊断标志物和遗传决定因素。然而,相关信息分散在大量文献中,这使得研究人员难以研究耐药性的分子机制。因此,我们从 465 项研究中手动收集了 6 种分枝杆菌中 73 种化合物和 132 种分子(包括编码基因和非编码 RNA)之间的 1707 个经过精心整理的关联。我们的工作还总结和记录了分子流行病学和机制探索研究的实验细节。此外,还提取了耐多药和广泛耐药的分子,以解释导致抗结核药物交叉耐药的分子机制。最后,我们构建了一个名为 MycoResistance 的综合存储库,这是一个用户友好的界面,可以方便地浏览、搜索和下载所有相关条目。我们希望这个精心制作的数据库将成为解释耐药性分枝杆菌菌株机制、精确诊断和有效治疗的有益资源。

相似文献

1
MycoResistance: a curated resource of drug resistance molecules in Mycobacteria.抗真菌药物数据库:抗真菌药物耐药性相关基因及突变位点数据库
Database (Oxford). 2019 Jan 1;2019. doi: 10.1093/database/baz074.
2
[Frontier of mycobacterium research--host vs. mycobacterium].[分枝杆菌研究前沿——宿主与分枝杆菌]
Kekkaku. 2005 Sep;80(9):613-29.
3
Inhibitors of mycobacterial efflux pumps as potential boosters for anti-tubercular drugs.分枝杆菌外排泵抑制剂作为抗结核药物的潜在增效剂。
Expert Rev Anti Infect Ther. 2012 Sep;10(9):983-98. doi: 10.1586/eri.12.89.
4
Rationalization and prediction of drug resistant mutations in targets for clinical anti-tubercular drugs.临床抗结核药物靶标耐药突变的合理化与预测。
J Biomol Struct Dyn. 2013;31(1):44-58. doi: 10.1080/07391102.2012.691361. Epub 2012 Jul 18.
5
Anti-mycobacterial activities of synthetic cationic α-helical peptides and their synergism with rifampicin.合成阳离子α-螺旋肽的抗分枝杆菌活性及其与利福平的协同作用。
Biomaterials. 2014 Feb;35(6):2032-8. doi: 10.1016/j.biomaterials.2013.11.035. Epub 2013 Dec 4.
6
[Clinical application of testing methods on acid-fast bacteria].抗酸菌检测方法的临床应用
Kekkaku. 2005 Feb;80(2):95-111.
7
[Development of antituberculous drugs: current status and future prospects].[抗结核药物的研发:现状与未来前景]
Kekkaku. 2006 Dec;81(12):753-74.
8
Detection of resistance to anti-tuberculosis drugs in the clinical isolates of Mycobacterium tuberculosis from Slovakia through comparison between phenotypic and genetic methods and evaluation of resistance levels with clinical parameter.通过表型和基因方法比较以及与临床参数评估耐药水平,从斯洛伐克的结核分枝杆菌临床分离株中检测抗结核药物耐药性。
J Physiol Pharmacol. 2019 Feb;70(1). doi: 10.26402/jpp.2019.1.10. Epub 2019 Jun 3.
9
Computational discovery of potent drugs to improve the treatment of pyrazinamide resistant Mycobacterium tuberculosis mutants.计算发现强效药物,改善耐吡嗪酰胺结核分枝杆菌突变体的治疗效果。
J Cell Biochem. 2018 Sep;119(9):7328-7338. doi: 10.1002/jcb.27033. Epub 2018 May 15.
10
u-CARE: user-friendly Comprehensive Antibiotic resistance Repository of Escherichia coli.u-CARE:用户友好型大肠杆菌综合抗生素耐药性知识库
J Clin Pathol. 2015 Aug;68(8):648-51. doi: 10.1136/jclinpath-2015-202927. Epub 2015 May 2.

引用本文的文献

1
Efficient mining of natural products from Mangrove streptomyces using NP-PRESS.使用NP-PRESS从红树林链霉菌中高效挖掘天然产物
Arch Microbiol. 2025 Jun 21;207(8):182. doi: 10.1007/s00203-025-04380-6.
2
Mutations and insights into the molecular mechanisms of resistance of Mycobacterium tuberculosis to first-line.结核分枝杆菌对一线药物耐药的分子机制的突变与见解。
Genet Mol Biol. 2023 Jan 23;46(1 Suppl 2):e20220261. doi: 10.1590/1678-4685-GMB-2022-0261. eCollection 2023.
3
DRESIS: the first comprehensive landscape of drug resistance information.

本文引用的文献

1
Expression analysis of 10 efflux pump genes in multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis clinical isolates.10 种外排泵基因在耐多药和广泛耐药结核分枝杆菌临床分离株中的表达分析。
J Glob Antimicrob Resist. 2019 Jun;17:201-208. doi: 10.1016/j.jgar.2019.01.003. Epub 2019 Jan 14.
2
Drug-resistant tuberculosis: challenges and opportunities for diagnosis and treatment.耐药性结核病:诊断和治疗的挑战与机遇。
Curr Opin Pharmacol. 2018 Oct;42:7-15. doi: 10.1016/j.coph.2018.05.013. Epub 2018 Jun 6.
3
Evolution of drug resistance in Mycobacterium tuberculosis: a review on the molecular determinants of resistance and implications for personalized care.
DRESIS:首个全面的耐药性信息全景图。
Nucleic Acids Res. 2023 Jan 6;51(D1):D1263-D1275. doi: 10.1093/nar/gkac812.
4
A Highly Sensitive and Specific Detection Method for Fluoroquinolone Resistance Mutations Utilizing the CRISPR-Cas13a System.一种利用CRISPR-Cas13a系统检测氟喹诺酮耐药突变的高灵敏度和特异性检测方法。
Front Microbiol. 2022 May 13;13:847373. doi: 10.3389/fmicb.2022.847373. eCollection 2022.
5
Tuberculosis drug resistance profiling based on machine learning: A literature review.基于机器学习的结核病耐药性分析:文献综述。
Braz J Infect Dis. 2022 Jan-Feb;26(1):102332. doi: 10.1016/j.bjid.2022.102332. Epub 2022 Feb 15.
6
HARP: a database of structural impacts of systematic missense mutations in drug targets of .HARP:一个关于……药物靶点中系统性错义突变结构影响的数据库。 (原文中“of”后面内容缺失)
Comput Struct Biotechnol J. 2020 Nov 19;18:3692-3704. doi: 10.1016/j.csbj.2020.11.013. eCollection 2020.
7
Genomics, Computational Biology and Drug Discovery for Mycobacterial Infections: Fighting the Emergence of Resistance.用于分枝杆菌感染的基因组学、计算生物学与药物发现:对抗耐药性的出现
Front Genet. 2020 Sep 4;11:965. doi: 10.3389/fgene.2020.00965. eCollection 2020.
8
Cryo-EM snapshots of mycobacterial arabinosyltransferase complex EmbB-AcpM.结核分枝杆菌阿拉伯糖基转移酶复合物 EmbB-AcpM 的冷冻电镜快照
Protein Cell. 2020 Jul;11(7):505-517. doi: 10.1007/s13238-020-00726-6. Epub 2020 May 3.
结核分枝杆菌耐药性的演变:耐药分子决定因素及其对个体化治疗的影响综述。
J Antimicrob Chemother. 2018 May 1;73(5):1138-1151. doi: 10.1093/jac/dkx506.
4
DrugBank 5.0: a major update to the DrugBank database for 2018.DrugBank 5.0:2018 年 DrugBank 数据库的重大更新。
Nucleic Acids Res. 2018 Jan 4;46(D1):D1074-D1082. doi: 10.1093/nar/gkx1037.
5
Evolution of Phenotypic and Molecular Drug Susceptibility Testing.表型和分子药敏试验的演变
Adv Exp Med Biol. 2017;1019:221-246. doi: 10.1007/978-3-319-64371-7_12.
6
Antimicrobial resistance in Mycobacterium tuberculosis: mechanistic and evolutionary perspectives.结核分枝杆菌的耐药性:机制和进化观点。
FEMS Microbiol Rev. 2017 May 1;41(3):354-373. doi: 10.1093/femsre/fux011.
7
Correlating rrs and eis promoter mutations in clinical isolates of Mycobacterium tuberculosis with phenotypic susceptibility levels to the second-line injectables.将结核分枝杆菌临床分离株中rrs和eis启动子突变与对二线注射剂的表型药敏水平相关联。
Int J Mycobacteriol. 2016 Mar;5(1):1-6. doi: 10.1016/j.ijmyco.2015.09.001. Epub 2015 Oct 1.
8
General and advanced diagnostic tools to detect Mycobacterium tuberculosis and their drug susceptibility: a review.用于检测结核分枝杆菌及其药物敏感性的常规和先进诊断工具:综述
Eur J Clin Microbiol Infect Dis. 2015 May;34(5):851-61. doi: 10.1007/s10096-014-2306-5. Epub 2015 Jan 6.
9
Treatment outcomes of patients with multidrug-resistant and extensively drug-resistant tuberculosis according to drug susceptibility testing to first- and second-line drugs: an individual patient data meta-analysis.根据一线和二线药物药敏试验结果分析耐多药和广泛耐药结核病患者的治疗结局:一项个体患者数据荟萃分析。
Clin Infect Dis. 2014 Nov 15;59(10):1364-74. doi: 10.1093/cid/ciu619. Epub 2014 Aug 5.
10
Characterization of a novel mutation in the overlap of tlyA and ppnK involved in capreomycin resistance in Mycobacterium.结核分枝杆菌中参与卷曲霉素抗性的tlyA和ppnK重叠区新突变的特征分析
IUBMB Life. 2014 Jun;66(6):405-14. doi: 10.1002/iub.1277. Epub 2014 May 29.